Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Plasminogen | ||
Ligand | BDBM50115875 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEBML_155433 | ||
Ki | 1700±n/a nM | ||
Citation | Mackman, RL; Hui, HC; Breitenbucher, JG; Katz, BA; Luong, C; Martelli, A; McGee, D; Radika, K; Sendzik, M; Spencer, JR; Sprengeler, PA; Tario, J; Verner, E; Wang, J 2-(2-Hydroxy-3-alkoxyphenyl)-1H-benzimidazole-5-carboxamidine derivatives as potent and selective urokinase-type plasminogen activator inhibitors. Bioorg Med Chem Lett12:2019-22 (2002) [PubMed] | ||
More Info.: | Get all data from this article, Assay Method | ||
Plasminogen | |||
Name: | Plasminogen | ||
Synonyms: | Activation peptide | Angiostatin | PLG | PLMN_HUMAN | Plasmin | Plasmin heavy chain A | Plasmin heavy chain A, short form | Plasmin light chain B | ||
Type: | Enzyme | ||
Mol. Mass.: | 90579.18 | ||
Organism: | Homo sapiens (Human) | ||
Description: | n/a | ||
Residue: | 810 | ||
Sequence: |
| ||
BDBM50115875 | |||
n/a | |||
Name | BDBM50115875 | ||
Synonyms: | 6-Fluoro-2-[2-hydroxy-3-(4-methyl-cyclohexyloxy)-phenyl]-1H-benzoimidazole-5-carboxamidine | CHEMBL62509 | ||
Type | Small organic molecule | ||
Emp. Form. | C21H23FN4O2 | ||
Mol. Mass. | 382.4313 | ||
SMILES | C[C@H]1CC[C@H](CC1)Oc1cccc(-c2nc3cc(F)c(cc3[nH]2)C(N)=N)c1O |wD:4.7,1.0,(9.17,-1.34,;7.63,-1.36,;6.84,-.03,;5.3,-.05,;4.56,-1.4,;5.34,-2.73,;6.87,-2.71,;3.02,-1.43,;2.22,-.1,;2.97,1.25,;2.17,2.57,;.63,2.54,;-.11,1.19,;-1.65,1.17,;-2.54,-.09,;-4.01,.37,;-5.32,-.44,;-6.66,.32,;-7.99,-.47,;-6.69,1.86,;-5.37,2.64,;-4.03,1.91,;-2.58,2.4,;-8.04,2.61,;-9.37,1.81,;-8.06,4.14,;.68,-.12,;-.07,-1.48,)| | ||
Structure |